Correlation Between NewAmsterdam Pharma and Amgen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both NewAmsterdam Pharma and Amgen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NewAmsterdam Pharma and Amgen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NewAmsterdam Pharma and Amgen Inc, you can compare the effects of market volatilities on NewAmsterdam Pharma and Amgen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NewAmsterdam Pharma with a short position of Amgen. Check out your portfolio center. Please also check ongoing floating volatility patterns of NewAmsterdam Pharma and Amgen.

Diversification Opportunities for NewAmsterdam Pharma and Amgen

-0.7
  Correlation Coefficient

Excellent diversification

The 3 months correlation between NewAmsterdam and Amgen is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding NewAmsterdam Pharma and Amgen Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amgen Inc and NewAmsterdam Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NewAmsterdam Pharma are associated (or correlated) with Amgen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amgen Inc has no effect on the direction of NewAmsterdam Pharma i.e., NewAmsterdam Pharma and Amgen go up and down completely randomly.

Pair Corralation between NewAmsterdam Pharma and Amgen

Given the investment horizon of 90 days NewAmsterdam Pharma is expected to generate 2.37 times more return on investment than Amgen. However, NewAmsterdam Pharma is 2.37 times more volatile than Amgen Inc. It trades about 0.16 of its potential returns per unit of risk. Amgen Inc is currently generating about -0.23 per unit of risk. If you would invest  1,702  in NewAmsterdam Pharma on September 1, 2024 and sell it today you would earn a total of  283.00  from holding NewAmsterdam Pharma or generate 16.63% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

NewAmsterdam Pharma  vs.  Amgen Inc

 Performance 
       Timeline  
NewAmsterdam Pharma 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in NewAmsterdam Pharma are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak primary indicators, NewAmsterdam Pharma unveiled solid returns over the last few months and may actually be approaching a breakup point.
Amgen Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Amgen Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

NewAmsterdam Pharma and Amgen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with NewAmsterdam Pharma and Amgen

The main advantage of trading using opposite NewAmsterdam Pharma and Amgen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NewAmsterdam Pharma position performs unexpectedly, Amgen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amgen will offset losses from the drop in Amgen's long position.
The idea behind NewAmsterdam Pharma and Amgen Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Global Correlations
Find global opportunities by holding instruments from different markets
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments